Pennant Group to participate in the 2026 Oppenheimer annual healthcare Conference. Pennant Group, Inc. - GlobeNewswire - Mon Mar 16, 5:15PM CDT EAGLE, Idaho, March 16, 2026 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2026. Brent Guerisoli, Chief Executive Officer, and Lynette Walbom, Chief Financial Officer will participate in a fireside chat on March 18, 2026 at 9:40 a.m. Eastern Time. A live webcast of the event will be accessible at the following address: investor.pennantgroup.com/events-and-presentations. About Pennant The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services throughout the United States. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com. Contact Information This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

The Pennant Group's shares have risen 33% to $34.03 over the past six months, outperforming the S&P 500 by 30 percentage points following strong quarterly results. However, analysts cite three concerns about the stock. First, with just $941.5 million in trailing 12-month revenue, the company lacks the scale needed in healthcare, where economies of scale provide competitive advantages. Second, its free cash flow margin averaged only 2% over five years, limiting reinvestment opportunities. Third, the company carries $453.2 million in debt against just $17.02 million in cash, resulting in a concerning net-debt-to-EBITDA ratio of 6×. The high leverage increases financial risk, particularly if profitability declines or market conditions deteriorate unexpectedly.

The Pennant Group reported full-year 2025 revenue of $947.7 million, up 36.3% year-over-year, with GAAP diluted earnings per share of $0.84 and adjusted diluted earnings per share of $1.18. Fourth-quarter revenue reached $289.3 million, a 53.2% increase over the prior year quarter. The home health and hospice segment drove growth, with revenue rising 41.0% to $732.7 million for the year. Total home health admissions increased 44.1% whilst hospice average daily census grew 28.6%. The senior living segment generated $215.0 million in revenue, up 22.3%, with fourth-quarter occupancy reaching 80.6%. For 2026, Pennant projects revenue between $1.13 billion and $1.17 billion, with adjusted earnings per share of $1.26 to $1.36. The guidance includes $191 million to $200 million in revenue from former UnitedHealth and Amedisys assets.